Business
Expect Nifty to correct in the mid-term
Updated : Sep 25, 2018, 06:00 AM IST
Continuous selling pressure from the foreign institutional investors (FII), rupee depreciation, adverse macroeconomic factors, uncertainty on national and state election, and overvalued stocks and indices – all these factors together can lead to a correction in the market.
Infosys, Sun Pharma, Dr Reddy's and SBI may remain bullish.
There might be some recovery in the NBFC stocks, while Pharma and IT will remain positive especially amid the current currency scenario.
Expect Nifty to correct in the mid-term.
Rising brent crude, escalating trade war, weakness in rupee and liquidity tightness in the bond market impacted the markets.
Prakarsh Gagdani, CEO, 5paisa.com